MIR1246 in body fluids as a biomarker for pancreatic cancer

Pancreatic cancer is an aggressive tumor associated with poor survival, and early detection is important to improve patient outcomes. In the present study, we examined MIR1246 expression as a biomarker of pancreatic cancer. Total RNA was extracted from serum, urine and saliva samples from healthy su...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishige, Fumitaka, Hoshino, Isamu, Iwatate, Yosuke, Chiba, Satoshi, Arimitsu, Hidehito, Yanagibashi, Hiroo, Nagase, Hiroki, Takayama, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250935/
https://www.ncbi.nlm.nih.gov/pubmed/32457495
http://dx.doi.org/10.1038/s41598-020-65695-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250935/
https://www.ncbi.nlm.nih.gov/pubmed/32457495
http://dx.doi.org/10.1038/s41598-020-65695-6

Ejemplares similares